Related Experiment Video
Updated: Apr 3, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Overview of Fungal Infections--The Italian Experience
1Infectious Diseases Division, Santa Maria Misericordia Hospital, Udine, Italy.
Abstract:
The incidence of severe fungal infections has increased worldwide and represents a serious threat, especially among immunocompromised and critically ill patients. Most common pulmonary fungal infections include aspergillosis, cryptococcosis, and Pneumocystis jiroveci pneumonia. Among nosocomial bloodstream infections, Candida spp. is the most common isolated fungus. Mortality rates up to 60% in critically ill patients with Candida infections and 90% in hematological patients with invasive aspergillosis are reported. Furthermore, fungal infections contribute to high morbidity and prolonged hospitalizations. Since standard cultural methods can show low sensitivity or provide delayed responses, new non-culture-dependent methods such as galactomannan β-D-glucan are now available. Novel antifungal compounds (e.g., amphotericin B lipid formulations, last-generation azoles, and echinocandins) have been introduced in the recent years. Nevertheless, despite new advances the appropriate use of diagnostic assays along with a thorough therapeutic management remain the key to ensure an early appropriate targeted treatment that represents the crucial factor to attain a successful approach to severe fungal infections.
Insights
Severe fungal infections are a growing global threat, particularly for vulnerable patients. Early diagnosis and targeted treatment are crucial for successful management and improved outcomes.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Critical Care Medicine
Background:
- Severe fungal infections are increasing globally, posing significant risks to immunocompromised and critically ill individuals.
- Common infections include pulmonary aspergillosis, cryptococcosis, Pneumocystis jiroveci pneumonia, and Candida bloodstream infections.
- These infections lead to high mortality rates (up to 90% for invasive aspergillosis) and significant morbidity.
Purpose of the Study:
- To review the current landscape of severe fungal infections.
- To highlight challenges in diagnosis and treatment.
- To emphasize the importance of integrated diagnostic and therapeutic strategies.
Main Methods:
- Review of recent literature on fungal infections, diagnostics, and therapeutics.
- Discussion of emerging diagnostic tools (galactomannan, β-D-glucan).
- Overview of novel antifungal agents (lipid formulations, azoles, echinocandins).
Main Results:
- Standard fungal culture methods have limitations in sensitivity and speed.
- Non-culture-based methods offer improved diagnostic capabilities.
- New antifungal compounds provide expanded treatment options.
Conclusions:
- Effective management of severe fungal infections relies on early, accurate diagnosis.
- Appropriate use of diagnostic assays and novel antifungal therapies is essential.
- Integrated diagnostic and therapeutic approaches are key to successful patient outcomes.
Related Concept Videos
Overview of Fungi
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Microsporidia
Fungal Group Zygomycota
Fungal Phylum Ascomycota
Fungal Phylum Basidiomycota

